Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Muraro

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|September 9, 2022
Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patientsElena Muraro, Fabio Del Ben, Matteo Turetta, et al.
Cancer Immunology Research|March 25, 2016
Broadening Specificity and Enhancing Cytotoxicity of Adoptive T Cells for Nasopharyngeal Carcinoma ImmunotherapyDamiana Antonia Faè, Debora Martorelli, Katy Mastorci, et al.
Frontiers in Immunology|January 31, 2022
KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast CancerElena Muraro, Mariangela De Zorzi, Gianmaria Miolo, et al.
Hematological Oncology|September 28, 2018
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patientFrancesca Caccuri, Elena Muraro, Annunziata Gloghini, et al.
The Prostate|September 6, 2024
Prognostic value of circulating tumor cells in oligorecurrent hormone-sensitive prostate cancer patients undergoing stereotactic body radiation therapyFabio Matrone, Fabio Del Ben, Marcella Montico, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2022
Emerging Role of Immunomonitoring to Predict the Clinical Outcome of Patients With Malignant Pleural Mesothelioma Treated With Radical Radiation TherapyMichela Cangemi, Marcella Montico, Marco Trovo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 10, 2021
IgG antibodies against SARS-CoV-2 decay but persist 4 months after vaccination in a cohort of healthcare workersGiulia Brisotto, Elena Muraro, Marcella Montico, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 26, 2017
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trialMarco Trovo, Carlo Furlan, Jerry Polesel, et al.
Frontiers in Immunology|November 23, 2017
Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast CancerElena Muraro, Carlo Furlan, Michele Avanzo, et al.
International Journal of Cancer|February 24, 2015
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV settingDebora Martorelli, Elena Muraro, Katy Mastorci, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|September 9, 2022
Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patientsElena Muraro, Fabio Del Ben, Matteo Turetta, et al.
Cancer Immunology Research|March 25, 2016
Broadening Specificity and Enhancing Cytotoxicity of Adoptive T Cells for Nasopharyngeal Carcinoma ImmunotherapyDamiana Antonia Faè, Debora Martorelli, Katy Mastorci, et al.
Frontiers in Immunology|January 31, 2022
KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast CancerElena Muraro, Mariangela De Zorzi, Gianmaria Miolo, et al.
Hematological Oncology|September 28, 2018
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patientFrancesca Caccuri, Elena Muraro, Annunziata Gloghini, et al.
The Prostate|September 6, 2024
Prognostic value of circulating tumor cells in oligorecurrent hormone-sensitive prostate cancer patients undergoing stereotactic body radiation therapyFabio Matrone, Fabio Del Ben, Marcella Montico, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2022
Emerging Role of Immunomonitoring to Predict the Clinical Outcome of Patients With Malignant Pleural Mesothelioma Treated With Radical Radiation TherapyMichela Cangemi, Marcella Montico, Marco Trovo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 10, 2021
IgG antibodies against SARS-CoV-2 decay but persist 4 months after vaccination in a cohort of healthcare workersGiulia Brisotto, Elena Muraro, Marcella Montico, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 26, 2017
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trialMarco Trovo, Carlo Furlan, Jerry Polesel, et al.
Frontiers in Immunology|November 23, 2017
Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast CancerElena Muraro, Carlo Furlan, Michele Avanzo, et al.
International Journal of Cancer|February 24, 2015
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV settingDebora Martorelli, Elena Muraro, Katy Mastorci, et al.
Pageof 5